Table 2.

Subjects studied in 46 randomized controlled trials reporting on QOL

	Number of trials (%)
Subjects	English Reports	Japanese Reports	Total
Oncology	15 (46.9)	11 (78.6)	26 (56.5)
Cardiovascular diseases	5 (15.6)	0 (0.0)	5 (10.9)
Urology	4 (12.5)	2 (14.3)	6 (13.0)
Gastrointestinal diseases	3 (9.4)	1 (7.1)	4 (8.7)
Respiratory	2 (6.3)	0 (0.0)	2 (4.3)
Dentistry	1 (3.1)	0 (0.0)	1 (2.2)
Infection	1 (3.1)	0 (0.0)	1 (2.2)
Health*	1 (3.1)	0 (0.0)	1 (2.2)
Total	32 (100.0)	14 (100.0)	46 (100.0)

* Health is defined here as the effect of captopril during exercise